Resources

Featured

Ending an epidemic: Prioritizing people who inject drugs in HCV elimination efforts
July 2018

Fuelled by political will, resources for cost-effective, evidence-based prevention programmes and revolutionary advances in hepatitis C virus (HCV) treatment, momentum is building towards halting a deadly global epidemic. Worldwide, an estimated 71 million people are living with hepatitis C, a blood- borne virus that infects liver cells.

English version

Spanish version / Versión en español

Russian version / Русская версия

Peer-reviewed publications

Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low‐ to high‐income settings: making sure no one is left behind
Journal of the International AIDS Society | April 2018

Towards global viral hepatitis elimination for all patients in all income settings
Journal of the International AIDS Society | April 2018

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
Journal of the International AIDS Society | July 2017

Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Hepatology, Medicine and Policy | April 2017

Blog posts

How to meet the first-ever global hepatitis targets
June 2016

Adopted Global Health Sector Strategies for HIV, viral hepatitis and sexually transmitted infections
June 2016

Policy briefs

Ending an epidemic: Prioritizing people who inject drugs in HCV elimination efforts

English version

Spanish version / Versión en español
Poner fin a una epidemia: Priorizando a las personas que se inyectan drogas en los esfuerzos para eliminar el virus de la hepatitis C

Russian version / Русская версия
Покончить с эпидемией: Приоритизация людей, употребляющих инъекционные наркотики, в усилиях по искоренению вирусного гепатита С